New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia

Author： Cruz Constança S   Cruz Luzia S   Domingues Gustavo S   Marcílio de Souza Carlos A  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.4, 2005-07, pp. : 677-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the risk of hyperkalaemia in heart failure?

By Bielecka-Dabrowa Agata   Rysz Jacek   Mikhailidis Dimitri P   Banach Maciej  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2329-2338

Informa Healthcare

Access to resources Recommend Favorite

Rationale for the Use of Aldosterone Antagonists in Congestive Heart Failure

By Rocha R.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 723-731

Adis International

Access to resources Recommend Favorite

Anti-aldosterone therapy in the treatment of heart failure: new thoughts on an old hormone

By Delyani J.A.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 753-759

Informa Healthcare

Access to resources Recommend Favorite

Diastolic Heart Failure in the Elderly and the Potential Role of Aldosterone Antagonists

By Kumar Ashwani  

Drugs & Aging, Vol. 23, Iss. 4, 2006-01 ,pp. : 299-308

Adis International

Access to resources Recommend Favorite

Aldosterone Antagonists: The Most Underutilized Class of Heart Failure Medications

By Guglin Maya   Khaled Esmaeel Awad   Polavaram Latha   Vankayala Hema  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 1, 2007-01 ,pp. : 75-79

Adis International

Access to resources Recommend Favorite